ONO Pharmaceutical Co (JP:4528) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ono Pharmaceutical Co., Ltd. is prioritizing corporate governance by increasing management transparency and enhancing board functions, with a focus on flexibility and sound decision-making. The company has appointed specialized outside directors to strengthen governance and has been systematically reducing its cross-shareholdings since 2018, aiming for a ratio under 10% of consolidated net assets. Additionally, Ono Pharmaceutical is committed to promoting diversity and inclusion, with specific goals to increase the representation of women in managerial positions.
For further insights into JP:4528 stock, check out TipRanks’ Stock Analysis page.